Erratum to: Do epinephrine auto-injectors have an unsuitable needle length in children and adolescents at risk for anaphylaxis from food allergy?

[This corrects the article DOI: 10.1186/s13223-016-0110-8.].

Erratum to: Allergy Asthma Clin Immunol (2016) 12:11 DOI 10.1186/s13223-016-0110-8

After publication of the article [1] it was brought to our attention that the incorrect length of needle was used for one of the epinephrine auto-injectors (EAI), Jext®. The length of the needle of the Jext® 0.15 mg is not 15.7 mm as mentioned in the paper, but 13 mm. After correcting the needle length for Jext®, the results of the study do not change aside for those involving Jext®. The results of the primary outcome variable for Jext® are now the same as the other high pressure EAIs (HPEAIs) and do not lead to intra-osseous injections 38% but 11% between 15 and 30 kg. This is the same risk as the Epipen® and the Auvi-Q®.